AGL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Agilon Health Inc. does not appear to be a strong buy for a beginner, long-term investor at this time. While there are positive indicators like insider and hedge fund buying, the lack of recent AI Stock Picker or SwingMax signals, combined with mixed analyst ratings and a bearish technical outlook, suggests holding off on investment until clearer opportunities arise.
The stock shows mixed technical signals. The MACD is negatively expanding (-0.518), indicating bearish momentum. RSI is neutral at 64.939. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is near its resistance level (R1: 115.858), which may limit upside potential. Historical candlestick analysis shows a high probability of negative returns in the next week (-2.04%) and month (-5.87%).
Hedge funds and insiders are significantly increasing their buying activity.
Analysts have upgraded price targets and ratings following strong Q1 results and improved Medicare Advantage outlook.
Bullish moving averages indicate long-term upward momentum.
MACD indicates bearish momentum.
Stock is near resistance levels, limiting short-term upside.
No recent AI Stock Picker or SwingMax signals.
Historical candlestick analysis predicts negative returns in the short term.
No financial data available for analysis.
Analyst ratings are mixed. While several firms have raised price targets and upgraded ratings due to strong Q1 results and improved guidance, others remain cautious, citing concerns about valuation, cash flow, and Medicare Advantage trends. Price targets range widely from $22 to $81.
